Cargando…
Drug Repurposing Against Angiotensin-Converting Enzyme-Related Carboxypeptidase (ACE2) Through Computational Approach
Ongoing novel coronavirus (COVID-19) with high mortality is an infectious disease in the world which epidemic in 2019 with human-human transmission. According to the literature, S-protein is one of the main proteins of COVID-19 that bind to the human cell receptor angiotensin-converting enzyme 2 (AC...
Autores principales: | Vaseghi, Golnaz, Golestaneh, Ali, Jafari, Leila, Ghasemi, Fahimeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885507/ https://www.ncbi.nlm.nih.gov/pubmed/36726422 http://dx.doi.org/10.4103/jmss.JMSS_66_20 |
Ejemplares similares
-
The carboxypeptidase angiotensin converting enzyme (ACE) shapes the MHC class I peptide repertoire
por: Shen, Xiao Z., et al.
Publicado: (2011) -
Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox
por: Javanmard, Shaghayegh Haghjooy, et al.
Publicado: (2020) -
Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome
por: Gómez, Juan, et al.
Publicado: (2020) -
Calmodulin interacts with angiotensin‐converting enzyme‐2 (ACE2) and inhibits shedding of its ectodomain
por: Lambert, Daniel W., et al.
Publicado: (2008) -
Structural characterization and angiotensin-converting enzyme (ACE) inhibitory mechanism of Stropharia rugosoannulata mushroom peptides prepared by ultrasound
por: Li, Wen, et al.
Publicado: (2022)